Meribank Biotech Co (ROCO:4724) Long-Term Capital Lease Obligation : NT$14.8 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Long-Term Capital Lease Obligation?

Meribank Biotech Co's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$14.8 Mil.

Meribank Biotech Co's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 (NT$24.3 Mil) to Jun. 2023 (NT$16.0 Mil) and declined from Jun. 2023 (NT$16.0 Mil) to Dec. 2023 (NT$14.8 Mil).

Meribank Biotech Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (NT$34.7 Mil) to Dec. 2022 (NT$24.3 Mil) and declined from Dec. 2022 (NT$24.3 Mil) to Dec. 2023 (NT$14.8 Mil).

Meribank Biotech Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Meribank Biotech Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Long-Term Capital Lease Obligation Chart

Meribank Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

18.68

49.93

34.73

24.25

14.81

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial							34.73	29.67	24.25	16.03	14.81

Meribank Biotech Co (ROCO:4724) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Meribank Biotech Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co (ROCO:4724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493

Website

http://www.meribank.com.tw

Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines